Azelastine Hydrochloride
- Product NDC
- 51525-0234
- 11-digit product format
- 515250234
- Labeler code
- 51525
- Product ID
- 51525-0234_ca6890f6-752e-4e86-96e9-4a4b451cbb31
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- azelastine hydrochloride
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Labeler
- Wallace Pharmaceuticals Inc.
- Application
- NDA022203
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2015-04-01
- Marketing end
- 0000-00-00
- Substance
- AZELASTINE HYDROCHLORIDE
- Active strength
- 206 ug/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51525-0234-3 | 51525023403 | 1 BOTTLE in 1 CARTON (51525-0234-3) > 200 SPRAY, METERED in 1 BOTTLE | 1 bottle | 2015-04-01 | 0000-00-00 | No | No | Current |